[Bromazepam in anxiety. Clinical evaluation (author's transl)].
In an open study, 30 patients with anxiety were treated with bromazepam 6 to 9 mg/day and followed-up for 15 days either as out-patients or in hospital. The results, assessed by anxiety scores, showed a 71,4% improvement, which was often perceptible as early as the third day of treatment. The best responses were obtained in patients who had not previously received anxiolytic drugs and in those who had less anxiety at the beginning of treatment. In two cases the drug was discontinued on account of daytime drowsiness.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D001960:Bromazepam / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged
D014151:Anti-Anxiety Agents; D001960:Bromazepam
Le bromazépam dans l'anxiété--Evaluation clinique. Etude ouverte concernant 30 malades hospitalisés ou suivis en ambulatoire.